RBC Capital Downgrades Adverum Biotech to Sector Perform, PT to $4.

Thursday, May 15, 2025 12:03 pm ET1min read
ADVM--
RBC--

RBC Capital Downgrades Adverum Biotech to Sector Perform, PT to $4.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet